ArticleScientific reports2022

Serum levels of IgM to phosphatidylcholine predict the response of multiple sclerosis patients to natalizumab or IFN-β.

Úrsula Muñoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.